ANDA 88368, held by Hospira. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 88368 (Lidocaine Hydrochloride In Plastic Container), held by Hospira, was first approved by FDA on Jul 31, 1984, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 31, 1984 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Lidocaine Hydrochloride In Plastic Container20% ยท injectable;injection | Lidocaine Hydrochloride | Discontinued |
| Dec 4, 2002 | Supplement 8Labeling | Approved | None posted |
| Oct 3, 1996 | Supplement 7Manufacturing | Approved | None posted |
| Jun 14, 1990 | Supplement 5Manufacturing | Approved | None posted |
| Jun 14, 1990 | Supplement 3Labeling | Approved | None posted |
| Aug 15, 1986 | Supplement 2Manufacturing | Approved | None posted |
| Apr 16, 1985 | Supplement 1Manufacturing | Approved | None posted |
| Jul 31, 1984 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters